3 days popular7 days popular1 month popular3 months popular

Furthering The Development Of Cancer Research: The Genomics Symposium

The symposium themed “The Era of Next Generation Sequencing in Cancer”, co-organized by BGI, the world’s largest genomics organization, and , was successfully conducted in , . Around 70 experts, scholars, and representatives from the local colleges, institutes and biotechnology industries attended the meeting with the aim to exchange their insights on high-throughput genomics and accelerate the further development of cancer research.

The symposium started with a friendly opening remark by Professor Charles Coombes, Director of Division of Cancer, Imperial College, and Hon Consultant Medical Oncologist, . He was delighted to be the chairman of the symposium, and said:” The symposium is a good start between and BGI. We are looking forward to more collaboration with BGI, one of the largest genomics organizations in the world. We are confident that we will make more breakthroughs together in the near future.”

After that, experts delivered several excellent presentations highlighting the advancements in cancer research, including “Cancer in BGI”, “Understanding estrogen receptor transcription in breast cancer”, “Genetic analysis of five cancers using single-cell sequencing”, “Genetic regulation of the rat cardiac methylome”, “Personalized epigenetic therapy in follicular lymphoma”, “Biomarker discovery through integrated next-generation sequencing (NGS) genomic analysis of neuroendocrine tumors”, among others.

Yingrui Li, Vice Director of BGI, shared several case studies on cancer genome research applying BGI’s NGS and bioinformatics technologies. He referred that the object of their studies is to make more contributions in cancer research and boost the transformation of scientific discoveries to benefit human health. He emphasized that, “NGS technologies, especially single-cell sequencing technology, elevate cancer research to a new level, enabling researchers to conduct cancer studies for the treatment and diagnosis of cancer at the cellular level and whole-genome level.”

Cancer genome research has been one of the most important fields in life science. With the rapid development of the NGS technologies, it allows researchers to comprehensively explore the characteristics underlying cancers. The symposium brought together leading scientists and researchers from UK and China, providing a truly international platform for strengthening the academic cooperation and communication between the two countries.

Source

BGI Shenzhen